Neuroleptic malignant syndrome

Common Name(s)

Neuroleptic malignant syndrome

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Neuroleptic malignant syndrome" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Neuroleptic malignant syndrome" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Neuroleptic malignant syndrome" returned 147 free, full-text research articles on human participants. First 3 results:

Neuroleptic malignant syndrome with thyroid disorder: An unusual case report.
 

Author(s): Fan Zhang, Parisa Kanzali, Vadim Rubin, Chris Paras, Joel Goldman

Journal: Medicine (Baltimore). 2017 Sep;96(39):e8191.

 

Neuroleptic malignant syndrome (NMS) is a life threatening neurologic emergency associated with neuroleptic or antipsychotic agent use. NMS is rarely related to thyroid disease.

Last Updated: 31 Dec 1969

Go To URL
Catatonic Symptoms Appearing before Autonomic Symptoms Help Distinguish Neuroleptic Malignant Syndrome from Malignant Catatonia.
 

Author(s): Takayuki Komatsu, Tomohisa Nomura, Hiroki Takami, So Sakamoto, Keiko Mizuno, Hajime Sekii, Kotaro Hatta, Manabu Sugita

Journal: Intern. Med.. ;55(19):2893-2897.

 

A 42-year-old Japanese woman with a 10-year history of schizophrenia was admitted due to a disturbance in consciousness that met the diagnostic criteria for both neuroleptic malignant syndrome (NMS) and malignant catatonia. Despite systemic supportive treatments, the catatonic symptoms ...

Last Updated: 31 Dec 1969

Go To URL
A Reversible Isolated Lesion in the Splenium of Corpus Callosum in a Patient with Probable Neuroleptic Malignant Syndrome -- Case Report.
 

Author(s): Chieh-Tsung Yeh, Chin-Hua Fu

Journal: Acta Neurol Taiwan. 2015 Sep;24(3)():87-91.

 

A reversible isolated lesion in the splenium of the corpus callosum (SCC) is rare. We present such a case in a young female patient with neuroleptic malignant syndrome (NMS) and elaborate on its proposed pathophysiology and the possible differential diagnoses.

Last Updated: 31 Dec 1969

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Neuroleptic malignant syndrome" returned 23 free, full-text review articles on human participants. First 3 results:

A Case Report of Catatonia and Neuroleptic Malignant Syndrome With Multiple Treatment Modalities: Short Communication and Literature Review.
 

Author(s): Yu-Jie Chiou, Yu Lee, Chin-Chuen Lin, Tiao-Lai Huang

Journal: Medicine (Baltimore). 2015 Oct;94(43):e1752.

 

We describe a case with complicated clinical presentations who was difficult to treat. We described the possible etiologies and differential diagnosis of neuroleptic malignant syndrome (NMS), catatonia, and infection, in details. This patient was also referred to neuro-intensive care ...

Last Updated: 31 Dec 1969

Go To URL
Neuroleptic Malignant Syndrome: A Review from a Clinically Oriented Perspective.
 

Author(s): Lurdes Tse, Alasdair M Barr, Vanessa Scarapicchia, Fidel Vila-Rodriguez

Journal: Curr Neuropharmacol. 2015 ;13(3):395-406.

 

Neuroleptic malignant syndrome (NMS) is a rare but potentially life-threatening side-effect that can occur in response to treatment with antipsychotic drugs. Symptoms commonly include hyperpyrexia, muscle rigidity, autonomic dysfunction and altered mental status. In the current review ...

Last Updated: 31 Dec 1969

Go To URL
Neuroleptic malignant syndrome with slight elevation of creatine kinase in serum: a brief review.
 

Author(s): Jordi León-Caballero, Leila Alba-Pale, Purificación Salgado-Serrano, Víctor Pérez-Solà

Journal: Actas Esp Psiquiatr. 2015 Sep;43(5):194-6.

 

Last Updated: 31 Dec 1969

Go To URL
 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Reducing Orthostatic Intolerance With Oral Rehydration in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients
 

Status: Recruiting

Condition Summary: Chronic Fatigue Syndrome; Myalgic Encephalomyelitis; Systemic Exertion Intolerance Disease (SEID); Postural Tachycardia Syndrome (POTS); Neurally Mediated Syncope (NMS)

 

Last Updated: 7 Aug 2017

Go to URL